# Solo Brands, Inc.: financial statements, quarterly

SBDS · OTC · CIK 1870600 · [Consumer discretionary](/sectors/consumer-discretionary.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/sbds.md) · [Financials](/companies/sbds/financials.md) · [Filings](/companies/sbds/filings.md) · [Insiders](/companies/sbds/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/sbds/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [110](/filings/0001870600-24-000114.md) | [165 d](/filings/0001870600-25-000029.md) | [85.3](/filings/0001870600-25-000059.md) | [132](/filings/0001870600-25-000102.md) | [94.1](/filings/0001870600-25-000124.md) | [144 d](/filings/0001870600-26-000013.md) | [77.3](/filings/0001870600-26-000035.md) | [92.3](/filings/0001870600-26-000044.md) | [53.0](/filings/0001870600-25-000124.md) | [94.0 d](/filings/0001870600-26-000013.md) | [62.9](/filings/0001870600-26-000035.md) | [88.5](/filings/0001870600-26-000044.md) |
| Gross profit | $m | [68.3](/filings/0001870600-24-000114.md) | [96.4 d](/filings/0001870600-25-000029.md) | [50.5](/filings/0001870600-25-000059.md) | [82.6](/filings/0001870600-25-000102.md) | [39.3](/filings/0001870600-25-000124.md) | [87.8 d](/filings/0001870600-26-000013.md) | [42.6](/filings/0001870600-26-000035.md) | [56.6](/filings/0001870600-26-000044.md) | [31.8](/filings/0001870600-25-000124.md) | [57.0 d](/filings/0001870600-26-000013.md) | [32.9](/filings/0001870600-26-000035.md) | [53.0](/filings/0001870600-26-000044.md) |
| Research and development | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Selling, general and administrative | $m | [57.0](/filings/0001870600-24-000114.md) | [84.3 d](/filings/0001870600-25-000029.md) | [48.4](/filings/0001870600-25-000059.md) | [70.8](/filings/0001870600-25-000102.md) | [61.1](/filings/0001870600-25-000124.md) | [81.8 d](/filings/0001870600-26-000013.md) | [39.0](/filings/0001870600-26-000035.md) | [47.7](/filings/0001870600-26-000044.md) | [39.5](/filings/0001870600-25-000124.md) | [50.1 d](/filings/0001870600-26-000013.md) | [33.2](/filings/0001870600-26-000035.md) | [42.6](/filings/0001870600-26-000044.md) |
| Operating income | $m | [(1.3)](/filings/0001870600-24-000114.md) | [(241) d](/filings/0001870600-25-000029.md) | [(6.4)](/filings/0001870600-25-000059.md) | [2.2](/filings/0001870600-25-000102.md) | [(115)](/filings/0001870600-25-000124.md) | [(55.2) d](/filings/0001870600-26-000013.md) | [(10.6)](/filings/0001870600-26-000035.md) | [(9.8)](/filings/0001870600-26-000044.md) | [(16.2)](/filings/0001870600-25-000124.md) | [(76.8) d](/filings/0001870600-26-000013.md) | [(4.7)](/filings/0001870600-26-000035.md) | [3.5](/filings/0001870600-26-000044.md) |
| Income tax | $m | [(6.2)](/filings/0001870600-24-000114.md) | [(33.0) d](/filings/0001870600-25-000029.md) | [(3.2)](/filings/0001870600-25-000059.md) | [2.7](/filings/0001870600-25-000102.md) | [(6.9)](/filings/0001870600-25-000124.md) | [(1.6) d](/filings/0001870600-26-000013.md) | [2.9](/filings/0001870600-26-000035.md) | [1.7](/filings/0001870600-26-000044.md) | [(0.6)](/filings/0001870600-25-000124.md) | [(0.6) d](/filings/0001870600-26-000013.md) | [(6.6)](/filings/0001870600-26-000035.md) | [0.1](/filings/0001870600-26-000044.md) |
| Net income | $m | [3.1](/filings/0001870600-24-000114.md) | [(127) d](/filings/0001870600-24-000024.md) | [(6.5)](/filings/0001870600-25-000124.md) | [(4.0)](/filings/0001870600-25-000124.md) | [(111)](/filings/0001870600-25-000124.md) | [(58.2) d](/filings/0001870600-26-000013.md) | [(18.6)](/filings/0001870600-26-000044.md) | [(20.8)](/filings/0001870600-26-000044.md) | [(22.9)](/filings/0001870600-25-000124.md) | [(83.2) d](/filings/0001870600-26-000013.md) | [(5.5)](/filings/0001870600-26-000044.md) | [(4.4)](/filings/0001870600-26-000044.md) |
| Diluted EPS | $ per share | [0.07](/filings/0001870600-24-000114.md) | not reported | [(0.06)](/filings/0001870600-25-000059.md) | [(2.14)](/filings/0001870600-25-000102.md) | [(47.72)](/filings/0001870600-25-000124.md) | not reported | [(8.27)](/filings/0001870600-26-000035.md) | [(8.93)](/filings/0001870600-26-000044.md) | [(9.22)](/filings/0001870600-25-000124.md) | not reported | [(2.18)](/filings/0001870600-26-000035.md) | [(1.72)](/filings/0001870600-26-000044.md) |
| Basic EPS | $ per share | [0.07](/filings/0001870600-24-000114.md) | not reported | [(0.06)](/filings/0001870600-25-000059.md) | [(2.14)](/filings/0001870600-25-000102.md) | [(47.72)](/filings/0001870600-25-000124.md) | not reported | [(8.27)](/filings/0001870600-26-000035.md) | [(8.93)](/filings/0001870600-26-000044.md) | [(9.22)](/filings/0001870600-25-000124.md) | not reported | [(2.18)](/filings/0001870600-26-000035.md) | [(1.72)](/filings/0001870600-26-000044.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Gross profit: us-gaap:GrossProfit
- Research and development: not reported
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:ProfitLoss, us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [16.6](/filings/0001870600-23-000064.md) | [19.8](/filings/0001870600-25-000029.md) | [15.4](/filings/0001870600-24-000045.md) | [20.1](/filings/0001870600-24-000099.md) | [12.5](/filings/0001870600-24-000114.md) | [12.0](/filings/0001870600-26-000013.md) | [206](/filings/0001870600-25-000059.md) | [18.1](/filings/0001870600-25-000102.md) | [16.3](/filings/0001870600-25-000124.md) | [20.0](/filings/0001870600-26-000044.md) | [16.5](/filings/0001870600-26-000035.md) | [35.4](/filings/0001870600-26-000044.md) |
| Current assets | $m | [185](/filings/0001870600-23-000064.md) | [196](/filings/0001870600-25-000029.md) | [192](/filings/0001870600-24-000045.md) | [188](/filings/0001870600-24-000099.md) | [172](/filings/0001870600-24-000114.md) | [172](/filings/0001870600-26-000013.md) | [373](/filings/0001870600-25-000059.md) | [149](/filings/0001870600-25-000102.md) | [128](/filings/0001870600-25-000124.md) | [140](/filings/0001870600-26-000044.md) | [148](/filings/0001870600-26-000035.md) | [136](/filings/0001870600-26-000044.md) |
| Total assets | $m | [899](/filings/0001870600-23-000064.md) | [659](/filings/0001870600-25-000029.md) | [648](/filings/0001870600-24-000045.md) | [642](/filings/0001870600-24-000099.md) | [553](/filings/0001870600-24-000114.md) | [495](/filings/0001870600-26-000013.md) | [692](/filings/0001870600-25-000059.md) | [460](/filings/0001870600-25-000102.md) | [431](/filings/0001870600-25-000124.md) | [360](/filings/0001870600-26-000044.md) | [363](/filings/0001870600-26-000035.md) | [343](/filings/0001870600-26-000044.md) |
| Current liabilities | $m | [62.7](/filings/0001870600-23-000064.md) | [88.6](/filings/0001870600-25-000029.md) | [68.5](/filings/0001870600-24-000045.md) | [75.3](/filings/0001870600-24-000099.md) | [110](/filings/0001870600-24-000114.md) | [122](/filings/0001870600-26-000013.md) | [487](/filings/0001870600-25-000059.md) | [41.1](/filings/0001870600-25-000102.md) | [40.1](/filings/0001870600-25-000124.md) | [47.4](/filings/0001870600-26-000044.md) | [41.6](/filings/0001870600-26-000035.md) | [43.4](/filings/0001870600-26-000044.md) |
| Long-term debt | $m | [160](/filings/0001870600-23-000064.md) | [143](/filings/0001870600-25-000029.md) | [163](/filings/0001870600-24-000045.md) | [153](/filings/0001870600-24-000099.md) | [151](/filings/0001870600-24-000114.md) | [142](/filings/0001870600-26-000013.md) | [0.0](/filings/0001870600-25-000059.md) | [238](/filings/0001870600-25-000102.md) | [234](/filings/0001870600-25-000124.md) | [240](/filings/0001870600-26-000044.md) | [261](/filings/0001870600-26-000035.md) | [245](/filings/0001870600-26-000044.md) |
| Current portion of debt | $m | [5.0](/filings/0001870600-23-000064.md) | [6.3](/filings/0001870600-25-000029.md) | [7.5](/filings/0001870600-24-000045.md) | [8.8](/filings/0001870600-24-000099.md) | [10.0](/filings/0001870600-24-000114.md) | [8.6](/filings/0001870600-26-000013.md) | [428](/filings/0001870600-25-000059.md) | [0.6](/filings/0001870600-25-000102.md) | [1.2](/filings/0001870600-25-000124.md) | [1.8](/filings/0001870600-26-000044.md) | [2.4](/filings/0001870600-26-000035.md) | [4.2](/filings/0001870600-26-000044.md) |
| Shareholders' equity | $m | [361](/filings/0001870600-23-000064.md) | [241](/filings/0001870600-25-000029.md) | [238](/filings/0001870600-24-000045.md) | [237](/filings/0001870600-24-000099.md) | [168](/filings/0001870600-24-000114.md) | [134](/filings/0001870600-26-000013.md) | [122](/filings/0001870600-25-000059.md) | [113](/filings/0001870600-25-000102.md) | [99.1](/filings/0001870600-25-000124.md) | [46.0](/filings/0001870600-26-000044.md) | [46.3](/filings/0001870600-26-000035.md) | [42.3](/filings/0001870600-26-000044.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [(12.6) d](/filings/0001870600-24-000114.md) | [23.3 d](/filings/0001870600-25-000029.md) | [(18.5)](/filings/0001870600-25-000059.md) | [15.7 d](/filings/0001870600-25-000102.md) | [0.4 d](/filings/0001870600-25-000124.md) | [13.0 d](/filings/0001870600-26-000013.md) | [(75.2)](/filings/0001870600-26-000035.md) | [10.9 d](/filings/0001870600-26-000044.md) | [11.2 d](/filings/0001870600-25-000124.md) | [6.4 d](/filings/0001870600-26-000013.md) | [(16.1)](/filings/0001870600-26-000035.md) | [36.1 d](/filings/0001870600-26-000044.md) |
| Capital expenditure | $m | [3.5 d](/filings/0001870600-24-000114.md) | [2.2 d](/filings/0001870600-25-000029.md) | [2.4](/filings/0001870600-25-000059.md) | [2.8 d](/filings/0001870600-24-000099.md) | [6.3 d](/filings/0001870600-24-000114.md) | [(4.0) d](/filings/0001870600-26-000013.md) | [3.2](/filings/0001870600-25-000059.md) | not reported | not reported | not reported | not reported | not reported |
| Share repurchases | $m | [8.5 d](/filings/0001870600-24-000114.md) | [0.0 d](/filings/0001870600-25-000029.md) | not reported | not reported | [0.0 d](/filings/0001870600-24-000114.md) | [0.0 d](/filings/0001870600-25-000029.md) | not reported | not reported | not reported | not reported | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [63.5](/filings/0001870600-23-000064.md) | [63.9](/filings/0001870600-24-000045.md) | [64.1](/filings/0001870600-24-000099.md) | [58.4](/filings/0001870600-24-000114.md) | [58.1](/filings/0001870600-25-000059.md) | [1.5](/filings/0001870600-25-000102.md) | [1.5](/filings/0001870600-25-000124.md) | [1.5](/filings/0001870600-26-000035.md) | [1.5](/filings/0001870600-26-000044.md) | [1.6](/filings/0001870600-25-000124.md) | [2.5](/filings/0001870600-26-000035.md) | [2.6](/filings/0001870600-26-000044.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 2,568,010 at 2026-08-07, from the cover of the [10-Q filed 2026-08-13](/filings/0001870600-26-000044.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:49 ET. No prices; not investment advice.